Bioscience Animal Health PCL

Bioscience Animal Health PCL EBIT Margin

The EBIT Margin (Operating Margin) of Bioscience Animal Health PCL (BIS.BK) as of Oct 16, 2026 is 0.88 %. In the previous year, EBIT Margin (Operating Margin) was 4.08 % — a change of -78.40% (lower).

EBIT Margin

0.88 %

YoY

-78.40%

Last updated:

EBIT Margin (Operating Margin) of Bioscience Animal Health PCL is 2025 0.88 % . EBIT Margin (Operating Margin) of Bioscience Animal Health PCL was 2024 4.08 % . It decreases by -78.40% lower compared to the previous year.

For Bioscience Animal Health PCL, the operating (EBIT) margin of 0.9% is down versus 4.9% a few years ago.

The Bioscience Animal Health PCL EBIT Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT Margin
Date
EBIT Margin
Jan 1, 2018
4.06 THB
Jan 1, 2019
7.38 THB
Jan 1, 2020
4.48 THB
Jan 1, 2021
4.87 THB
Jan 1, 2022
3.74 THB
Jan 1, 2023
2.83 THB
Jan 1, 2024
4.08 THB
Jan 1, 2025
0.88 THB
The Bioscience Animal Health PCL EBIT Margin history
YEAREBIT MarginYoY
0.88 %-78.40%
4.08 %+44.19%
2.83 %-24.28%
3.74 %-23.30%
4.87 %+8.81%
4.48 %-39.31%
7.38 %+81.62%
4.06 %-33.29%
6.09 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Bioscience Animal Health PCL Stock analysis

What does Bioscience Animal Health PCL do? Bioscience Animal Health PCL, listed on the Stock Exchange of Thailand with ticker BIS.BK and ISIN THA776010003, operates in the Health Care sector. The company is headquartered in Pak Kret, Thailand, and completed its initial public offering on May 5, 2022. Bioscience Animal Health PCL is engaged in the manufacturing, importing, and distribution of medical supplies, tools, equipment, and products for livestock and pets. The company emphasizes collaboration with specialist veterinarians to select products aimed at enhancing animal health. Its product portfolio includes antibiotics, additives, BiSMiX B-Series, BiSMiX SD Series, injections, mold inhibitors, water-soluble products, and vaccines. Specific antibiotic products mentioned are Omnicide FG II 1 Lit, Green Bioxide 20Liter, Salinopharm, Cevazuril, and Porcillin. Injection products include Zuprevo, Nuflor, Ceva, and Enzaprost. The company also provides services such as comprehensive farm advisory, disease prevention and surveillance programs, serological examination and diagnosis, biosafety and hygiene management, analysis of feed raw materials, preparation of feed formulations, feed production inspection and monitoring, and management and upskilling of farm personnel. The company's website is https://bis-group.com/. Bioscience Animal Health PCL is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Bioscience Animal Health PCL stock

EBIT Margin (Operating Margin) of Bioscience Animal Health PCL is 0.88 % in 2025.

EBIT Margin (Operating Margin) of Bioscience Animal Health PCL changed from 4.08 % to 0.88 %, representing a -78.40% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT Margin (Operating Margin) Bioscience Animal Health PCL since 2006 – with annual values, charts, and detailed analysis.

EBIT Margin measures operating profitability as a percentage of revenue. It shows how much profit a company makes from operations before interest and taxes.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBIT Margin (Operating Margin)'s Bioscience Animal Health PCL with sector peers and the industry average to assess whether it is attractive.

To evaluate EBIT Margin (Operating Margin)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT Margin (Operating Margin).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Bioscience Animal Health PCL

All Key Metrics — Bioscience Animal Health PCL